Date published: 2026-8-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cofilin 2 Double Nickase Plasmid (h): sc-401512-NIC

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • Cofilin 2 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
  • Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
  • One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
  • Cofilin 2 Double Nickase Plasmid (h) and Cofilin 2 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting CFL2. One or both designs may be available
  • Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Cofilin 2 Antibody (D-5): sc-166958
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    Cofilin 2 Double Nickase Plasmid (h)

    sc-401512-NIC
    20 µg
    $410.00

    Cofilin 2 Double Nickase Plasmid (h2)

    sc-401512-NIC-2
    20 µg
    $410.00

    CFL2 encodes cofilin 2, an actin-binding protein that regulates filament turnover by promoting F-actin severing and depolymerization, thereby shaping cytoskeletal dynamics required for contractility and cell morphology. In striated muscle, cofilin 2 supports sarcomere organization and myofibril maintenance through coordinated control of actin remodeling and actin–myosin interactions. CFL2 activity integrates with actin signaling networks downstream of Rho family GTPases and phosphoregulation pathways that tune actin filament stability. Disruption of CFL2 function has been linked to neuromuscular and myopathic phenotypes characterized by altered myofibrillar architecture, making it relevant for studies of muscle homeostasis and cytoskeleton-associated disease mechanisms.

    Cofilin 2 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the CFL2 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within CFL2. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt CFL2 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.

    To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of CFL2-disrupted clones.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.